| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |